Objectives: The purpose of this study is to investigate bone marrow metastasis in patients with Gastric cancer. Methods: We retrospectively evaluated patients with gastric cancer who applied to our clinic between 2010-2016. Results: 896 patients with gastric cancer were included in the study. Patients had metastatic bone marrow in 8 patients. When the laboratory results were evaluated; in 5 patients trombocytopenia with anemia were present, 2 patients had only tromboscytopenia, one patient had only anemia. In all patients white blood cell count was within normal range. The median survival of the 8 patients in our study was 72 days. In our chemoteraphy group (6 patients) median survival was 77 days (range, 49 to 145 days), in the non-treatment group was 7,5 days (range, 3 to 12 days). Conclusion: Gastric cancer with bone marrow metastasis is usually seen in younger patients, and is related to poorly differantiated subtypes and is a disease with worse prognosis. Median survival with paliative chemotraphy is under 3 months.
Corresponding Author: Ergun Y.